Penumbra (PEN) Non-Current Assets (2014 - 2026)
Penumbra (PEN) posted quarterly Non-Current Assets of $630.6 million for Q2 2026, up 3.49% year-over-year from $609.3 million in Q2 2025, and up 1.21% quarter-over-quarter from $623.0 million in Q1 2026.
Penumbra (PEN) Non-Current Assets (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Non-Current Assets for 13 consecutive years, with $630.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Non-Current Assets rose 3.49% year-over-year to $630.6 million; the TTM figure through Jun 2026 stood at $2.5 billion (up 3.96% YoY), while the FY2025 annual figure was $609.8 million, up 4.77% from the prior year.
- Non-Current Assets climbed to $630.6 million in Q2 2026 per PEN's latest filing, from $623.0 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $644.8 million in Q1 2024 and bottomed at $582.1 million in Q4 2024.
- Historically, Non-Current Assets has averaged $609.0 million across 5 years, with a median of $609.1 million in 2023.
- Annual changes were most pronounced in 2022 — Non-Current Assets surged 197.16% — and 2024, when it retreated 9.18%.
- Penumbra's Non-Current Assets stood at $615.2 million in 2022, then grew by 4.18% to $640.9 million in 2023, then decreased by 9.18% to $582.1 million in 2024, then grew by 4.77% to $609.8 million in 2025, then advanced by 3.41% to $630.6 million in 2026.
- Business Quant data shows PEN's Non-Current Assets at $630.6 million in Q2 2026, $623.0 million in Q1 2026, and $609.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Penumbra | 12.76 Bn | 12.10 Bn | 264.94 Mn | 630.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 630.60 Mn |
| Mar 31, 2026 | 623.03 Mn |
| Dec 31, 2025 | 609.84 Mn |
| Sep 30, 2025 | 602.85 Mn |
| Jun 30, 2025 | 609.33 Mn |
| Mar 31, 2025 | 593.60 Mn |
| Dec 31, 2024 | 582.06 Mn |
| Sep 30, 2024 | 587.37 Mn |
| Jun 30, 2024 | 590.77 Mn |
| Mar 31, 2024 | 644.82 Mn |
| Dec 31, 2023 | 640.90 Mn |
| Sep 30, 2023 | 599.90 Mn |
| Jun 30, 2023 | 604.66 Mn |
| Mar 31, 2023 | 608.81 Mn |
| Dec 31, 2022 | 615.19 Mn |
| Sep 30, 2022 | 597.98 Mn |
| Jun 30, 2022 | 609.94 Mn |
| Mar 31, 2022 | 611.25 Mn |
| Dec 31, 2021 | 562.78 Mn |
| Sep 30, 2021 | 305.25 Mn |